Abstract
The COVID-19 pandemic continues to be a worldwide public health concern. Although vaccines against this disease were rapidly developed, vaccination uptake has not been equal across all the segments of the population. In particular, it has been shown that there have been differences in vaccine uptake across different segments of the population. However, there are also differences in vaccination across geographical areas, which might be important to consider in the development of future public health vaccination policies. In this study, we examined the relationship between vaccination status (having received the first dose of a COVID-19 vaccine), and different socio-economic and geographical factors. Our results show that between October of 2021 and January of 2022, individuals from underrepresented communities were three times less likely to be vaccinated than White/Caucasian individuals across the province of Ontario in Canada, and that in some cases, within these groups, individuals in low-income brackets had significantly higher odds of vaccination when compared to their peers in high income brackets. Finally, we identified significantly lower odds of vaccination in the Central, East and West Health Regions of Ontario within certain underrepresented groups. This study shows that there is an ongoing need to better understand and address differences in vaccination uptake across diverse segments of the population of Ontario that the pandemic has largely impacted.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Fonds de recherche du Quebec Scholar Program (J1 in Artificial Intelligence and Digital Health, BN), the Natural Sciences and Engineering Research Council of Canada through the Discovery Grant Program (RGPID-560523-2020, BN), the Mathematics for Public Health (MfPH) Emerging Infectious Diseases Modelling Initiative (BN, AM), and the OMNI Emerging Infectious Disease Modelling Initiative (BN).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The collection of the data used in this study was approved by the Research Ethics Board from the University of Toronto, with approval number 40999.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The survey data used in this study was collected by the Fields Institute for Research in Mathematical Sciences. Those interested in accessing the survey data used in this study should contact directly the Fields Institute for Research in Mathematical Sciences. Data used for corrections, and the mapping of observations to their corresponding Health Regions can be found in the GitHub repository for this work.
